Chemical Reprogramming of Fibroblasts to Cardiomyocytes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell reprogramming methods are inefficient and often involve genetic changes, raising concerns about introduced mutations, particularly when using pluripotency factors that can lead to unwanted genetic alterations.
Innovation Solution
The use of a composition containing specific small molecules such as WNT agonists, GSK3 inhibitors, TGF-beta inhibitors, epigenetic modifiers, and adenylyl cyclase agonists, along with the induction of an Oct polypeptide, to directly convert non-cardiac cells into cardiac progenitor cells or cardiomyocytes without traversing the pluripotent state, thereby minimizing genetic changes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pluripotency factors are used for cell reprogramming, then reprogramming can be achieved, but genetic changes and mutations are introduced
Solution Approach 1:
The invention extracts and eliminates the harmful genetic manipulation step from the reprogramming process. Instead of introducing exogenous pluripotency factors that integrate into the genome, the method uses small molecule compounds that temporarily modulate gene expression without causing permanent genetic changes, thereby achieving reprogramming while removing the source of mutagenesis
Solution Approach 2:
The invention substitutes the mechanical/genetic approach (introducing foreign DNA and forcing transcription factor expression) with a chemical approach (using small molecules to modulate signaling pathways and epigenetic markers). This replacement of genetic manipulation with chemical modulation achieves the same reprogramming effect without the harmful side effects of genetic integration
2Reliability
If traditional reprogramming methods are used, then cell type conversion can be achieved, but reprogramming efficiency is low and process is slow
Solution Approach 1:
The invention applies preliminary action by treating cells with small molecules that pre-condition the cellular environment and prime the cells for reprogramming before the actual conversion process. This pre-treatment modifies epigenetic markers and activates signaling pathways in advance, making the cells more receptive to reprogramming signals and significantly accelerating the overall process
Solution Approach 2:
The invention employs parameter changes by systematically optimizing concentrations, treatment durations, and combinations of multiple small molecule compounds. By adjusting these chemical parameters, the method achieves high-efficiency reprogramming in a fraction of the time required by traditional methods, transforming a slow process into a rapid and scalable technique
Data Source
AI summary
Compositions and methods are described herein for chemically inducing cells that express a single pluripotency transcription factor to change their differentiation state and become cardiac cells, cardiac progenitor cells, cardiomyocytes, or a combination thereof.